Oyster Point Pharma, Inc.

Delisted

CIK 1720725fmd_0HCTF4T6AGS2VKF5R7E7DR966HManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2018 to Sep 30, 2022, 19 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.